Trail-r Is A Negative Regulator Of Innate Immune Responses
None
Patent Number: US7892539B2
Application Number: US200588459A
Inventor: Winoto, Astar | Diehl, Gretchen Elizabeth | Yue, Herman Heng
Priority Date: 24 Mar 2004
Priority Number: US7892539B2
Application Date: 23 Mar 2005
Publication Date: 22 Feb 2011
IPC Current: A61K003900 | A01K006700 | A61K003100 | A61K003817 | A61K0039395 | C07K0014705 | C12N001585 | C12Q000100 | G01N003353 | C07K001600 | C07K001622 | C07K001624 | C07K001628
US Class: 4241301 | 4350071 | 5140037 | 5303871 | 53038822 | 53038823 | 53038824 | 5303891 | 5303892 | 514002
Assignee Applicant: The Regents of the University of California
Title: Modulation of an innate immune response by altering TRIAL-R signaling
Usefulness: Modulation of an innate immune response by altering TRIAL-R signaling
Summary: The method is useful in modulating an innate immune response against infection or tumor.
Novelty: Modulating an innate immune response against infection by contacting cells associated with innate immune responses with an agent that alters tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) signaling
診斷/治療
癌症/腫瘤
7892539
Tech ID/UC Case 17393/2004-086-0 Related Cases 2004-086-0
美國
